Related Experiment Video
Updated: Jul 16, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
[Gene therapy for Parkinson's disease]
M Gómez Gallego1, A Fernández Barreiro
1Servicio de Neurología, Hospital Universitario Virgen de la Arritxaca, Murcia, Spain. mgomezg@um.es
Neurologia (Barcelona, Spain)
|February 23, 2007
Summary
Gene therapy offers a promising approach for Parkinson's disease (PD) treatment, particularly in vivo strategies using viral vectors. This review examines therapeutic trials and vector-specific advantages and disadvantages for managing PD complications.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Context:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- Current treatments do not prevent long-term motor and psychic complications.
- Gene therapy is an emerging treatment modality for neurodegenerative diseases.
Purpose:
- To review in vivo gene therapy strategies for Parkinson's disease.
- To examine conducted therapeutic trials.
- To discuss the advantages and disadvantages of various viral vectors used in PD gene therapy.
Summary:
- In vivo gene therapy, utilizing potent viral vectors, has shown significant promise in preclinical models of Parkinson's disease.
- This approach aims to address the limitations of current treatments in managing debilitating motor and psychic complications.
- The review focuses on evaluating the efficacy and safety profiles of different viral vectors employed in therapeutic trials.
Impact:
- Provides a comprehensive overview of gene therapy's potential in Parkinson's disease management.
- Highlights the importance of selecting appropriate viral vectors for successful therapeutic outcomes.
- Informs future research and clinical applications of gene therapy for neurodegenerative disorders.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...